Publications by authors named "Alessia Proment"

Claim this Profile
C
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
Raffaella De Maria, Chiara Donini, Sonia Capellero, Annamaria Massa, Federica Galvagno, Alessia Proment

Cancer Immunol Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
Raffaella De Maria, Chiara Donini, Sonia Capellero, Annamaria Massa, Federica Galvagno, Alessia Proment

Cancer Immunol Immunother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression.
Lucia Giordanengo, Alessia Proment, Virginia Botta, Francesca Picca, H M Waqas Munir

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
Federica Galvagno, Valeria Leuci, Annamaria Massa, Chiara Donini, Ramona Rotolo, Alessia Proment

Cancer Immunol Immunother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
Cristina Chiriaco, Chiara Donini, Marco Cortese, Stefano Ughetto, Chiara Modica, Alessia Proment

J Exp Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Letizia Vitali, Alessandra Merlini, Federica Galvagno, Alessia Proment, Dario Sangiolo

Biomedicines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, Ilaria Cerviere, Enrico Berrino, Alessia Proment

Int J Mol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
Chiara Donini, Ramona Rotolo, Alessia Proment, Massimo Aglietta, Dario Sangiolo

Cells· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis